TY - JOUR
T1 - Developing a community-supported risk reduction intervention for syringe exchange registrants and their drug-free family or friends
T2 - a pilot study
AU - Kidorf, Michael
AU - Latkin, Carl
AU - Brooner, Robert K.
AU - Yan, Haijuan
AU - Peirce, Jessica
N1 - Publisher Copyright:
© 2020 Taylor & Francis Group, LLC.
PY - 2020
Y1 - 2020
N2 - Background: People engaged in injection opioid use often have drug-free family or friends that could be mobilized to support risk reduction and treatment seeking. Objective: This pilot study evaluated the feasibility and preliminary efficacy of a 6-week community-supported risk reduction group intervention for syringe exchange program (SEP) registrants and drug-free network members. Method: The group provided risk reduction and treatment readiness education, with weekly assignments for participants to engage together in community activities designed to meet other drug-free people. Results: Thirty-nine SEP registrants (and 39 community supports) enrolled in the study, and 21 pairs attended at least one group. For this smaller sample, participants attended 67% of scheduled sessions and engaged in scheduled activities during 42% of the study weeks, with 48% of SEP participants (n = 10) choosing to enter substance use disorder treatment. SEP participants who entered treatment reported reduced rates of injection drug use, opioid use, and cocaine use. Conclusions: While this intervention shows promise for linking syringe exchange and substance use disorder treatment participation in select SEP registrants, outcomes demonstrating low demand and modest acceptability suggest that additional research is necessary to understand barriers to participation and motivate higher levels of engagement.
AB - Background: People engaged in injection opioid use often have drug-free family or friends that could be mobilized to support risk reduction and treatment seeking. Objective: This pilot study evaluated the feasibility and preliminary efficacy of a 6-week community-supported risk reduction group intervention for syringe exchange program (SEP) registrants and drug-free network members. Method: The group provided risk reduction and treatment readiness education, with weekly assignments for participants to engage together in community activities designed to meet other drug-free people. Results: Thirty-nine SEP registrants (and 39 community supports) enrolled in the study, and 21 pairs attended at least one group. For this smaller sample, participants attended 67% of scheduled sessions and engaged in scheduled activities during 42% of the study weeks, with 48% of SEP participants (n = 10) choosing to enter substance use disorder treatment. SEP participants who entered treatment reported reduced rates of injection drug use, opioid use, and cocaine use. Conclusions: While this intervention shows promise for linking syringe exchange and substance use disorder treatment participation in select SEP registrants, outcomes demonstrating low demand and modest acceptability suggest that additional research is necessary to understand barriers to participation and motivate higher levels of engagement.
KW - Syringe exchange
KW - risk reduction
KW - social support
KW - substance use disorder treatment
UR - http://www.scopus.com/inward/record.url?scp=85097400219&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097400219&partnerID=8YFLogxK
U2 - 10.1080/10550887.2020.1854033
DO - 10.1080/10550887.2020.1854033
M3 - Article
C2 - 33287681
AN - SCOPUS:85097400219
SN - 1055-0887
VL - 39
SP - 248
EP - 256
JO - Journal of Addictive Diseases
JF - Journal of Addictive Diseases
IS - 2
ER -